1. Home
  2. ARWR vs CNMD Comparison

ARWR vs CNMD Comparison

Compare ARWR & CNMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARWR
  • CNMD
  • Stock Information
  • Founded
  • ARWR 2003
  • CNMD 1970
  • Country
  • ARWR United States
  • CNMD United States
  • Employees
  • ARWR 525
  • CNMD N/A
  • Industry
  • ARWR Biotechnology: Pharmaceutical Preparations
  • CNMD Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • ARWR Health Care
  • CNMD Health Care
  • Exchange
  • ARWR Nasdaq
  • CNMD Nasdaq
  • Market Cap
  • ARWR 2.7B
  • CNMD 2.2B
  • IPO Year
  • ARWR 1993
  • CNMD 1987
  • Fundamental
  • Price
  • ARWR $22.04
  • CNMD $72.01
  • Analyst Decision
  • ARWR Buy
  • CNMD Buy
  • Analyst Count
  • ARWR 12
  • CNMD 6
  • Target Price
  • ARWR $42.70
  • CNMD $82.83
  • AVG Volume (30 Days)
  • ARWR 2.0M
  • CNMD 333.4K
  • Earning Date
  • ARWR 02-04-2025
  • CNMD 01-29-2025
  • Dividend Yield
  • ARWR N/A
  • CNMD 1.12%
  • EPS Growth
  • ARWR N/A
  • CNMD 127.53
  • EPS
  • ARWR N/A
  • CNMD 4.22
  • Revenue
  • ARWR $3,551,000.00
  • CNMD $1,288,116,000.00
  • Revenue This Year
  • ARWR $4,225.26
  • CNMD $6.69
  • Revenue Next Year
  • ARWR $59.48
  • CNMD $7.45
  • P/E Ratio
  • ARWR N/A
  • CNMD $16.88
  • Revenue Growth
  • ARWR N/A
  • CNMD 10.23
  • 52 Week Low
  • ARWR $17.05
  • CNMD $61.05
  • 52 Week High
  • ARWR $39.83
  • CNMD $114.80
  • Technical
  • Relative Strength Index (RSI)
  • ARWR 50.44
  • CNMD 46.45
  • Support Level
  • ARWR $21.48
  • CNMD $69.68
  • Resistance Level
  • ARWR $22.47
  • CNMD $76.34
  • Average True Range (ATR)
  • ARWR 1.27
  • CNMD 2.51
  • MACD
  • ARWR -0.23
  • CNMD -0.51
  • Stochastic Oscillator
  • ARWR 12.63
  • CNMD 25.93

About ARWR Arrowhead Pharmaceuticals Inc.

Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting hepatitis B, Alpha-1 Antitrypsin Deficiency, thrombosis and angioedema, clear-cell and renal cell carcinoma, and cardiovascular disease.

About CNMD CONMED Corporation

Conmed Corp is a Utica, New York-based medical equipment company that focuses on sports medicine procedures and general surgeries. The firm currently reports through two reporting units, orthopedic surgery, and general surgery. From a geographic perspective, the firm is U.S.-centric, with maximum domestic sales accounting for revenue, EMEA accounting for second place, APAC at third, and the non-U.S. Americas region driving the remaining revenue.

Share on Social Networks: